| Bevacizumab-induced hypertension: pathogenesis and management KN Syrigos, E Karapanagiotou, P Boura, C Manegold, K Harrington BioDrugs 25, 159-169, 2011 | 135 | 2011 |
| Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients EM Karapanagiotou, A Polyzos, KD Dilana, I Gratsias, P Boura, I Gkiozos, ... Lung Cancer 66 (3), 393-398, 2009 | 51 | 2009 |
| Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma I Pantazopoulos, P Boura, T Xanthos, K Syrigos European Respiratory Journal 41 (3), 706-715, 2013 | 49 | 2013 |
| Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer‐associated … K Syrigos, D Grapsa, R Sangare, I Evmorfiadis, AK Larsen, P Van Dreden, ... The oncologist 23 (11), 1372-1381, 2018 | 46 | 2018 |
| Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol EI Syrigou, EM Karapanagiotou, CV Alamara, PG Boura, MW Saif, ... Clinical colorectal cancer 8 (2), 106-109, 2009 | 37 | 2009 |
| Khorana score: νew predictor of early mortality in patients with lung adenocarcinoma I Vathiotis, EP Dimakakos, P Boura, A Ntineri, A Charpidou, G Gerotziafas, ... Clinical and Applied Thrombosis/Hemostasis 24 (8), 1347-1351, 2018 | 27 | 2018 |
| Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study EM Karapanagiotou, PG Boura, G Papamichalis, M Konstantinou, ... Anticancer research 29 (10), 4297-4301, 2009 | 23 | 2009 |
| The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives P Boura, S Loukides, D Grapsa, A Achimastos, K Syrigos Future Oncology 11 (15), 2193-2203, 2015 | 22 | 2015 |
| Endoscopic and endobronchial ultrasound-guided needle aspiration in the mediastinal staging of non-small cell lung cancer T Raptakis, P Boura, S Tsimpoukis, I Gkiozos, KN Syrigos Anticancer Research 33 (6), 2369-2376, 2013 | 14 | 2013 |
| PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost–effectiveness VKI Gkogkozotou, IC Gkiozos, AG Charpidou, EA Kotteas, PG Boura, ... Lung Cancer Management 7 (2), LMT02, 2018 | 12 | 2018 |
| Epithelioid hemangioendothelioma treated with bevacizumab: A case series E Merikas, D Grapsa, E Dikoudi, I Gkiozos, P Boura, A Charpidou, ... Cancer Treatment Communications 4, 59-64, 2015 | 5 | 2015 |
| Mesothelin and osteopontin I Pantazopoulos, T Xanthos, P Boura, K Syrigos European Respiratory Journal 42 (2), 557-558, 2013 | 3 | 2013 |
| The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer P Boura, D Grapsa, S Loukides, M Angelidou, K Tsakanika, N Syrigos, ... Lung Cancer Management 6 (2), 55-65, 2017 | 2 | 2017 |
| PO-53-Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma … P Boura, I Evmorfiadis, A Rousseau, A Charpidou, G Giozos, ... Thrombosis Research 140, S196, 2016 | 2 | 2016 |
| European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European … I Opitz, A Bille, U Dafni, K Nackaerts, L Ampollini, M de Perrot, L Brcic, ... Journal of Thoracic Oncology 18 (9), 1233-1247, 2023 | 1 | 2023 |
| The Khorana score as a predictor of mortality in lung adenocarcinoma K Syrigos, I Vathiotis, A Charpidou, P Boura, S Tsimpoukis, E Kokkotou, ... European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer K Syrigos, I Kotteas, M Paraskeva, I Gkiozos, P Boura, S Tsagouli, ... European Respiratory Journal 52 (suppl 62), 2018 | 1 | 2018 |
| Validation of the Khorana score in lung cancer patients: a new predictor of early mortality? I Vathiotis, E Dimakakos, P Boura, A Ntineri, A Charpidou, GT Gerotziafas, ... Thrombosis Research 164, S233, 2018 | 1 | 2018 |
| 45P Economic evaluation of two therapeutic approaches in non small cell lung cancer K Syrigos, A Somarakis, R Triggidou, I Kainis, P Boura, M Zontanos, ... Journal of Thoracic Oncology 11 (4), S74, 2016 | 1 | 2016 |
| Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study I Evmorfiadis, P Boura, A Rousseau, A Charpidou, G Giozos, ... Blood 124 (21), 4253, 2014 | 1 | 2014 |
